The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > VARIOUS DRUG RELATED TOPICS > Recovery and addiction > Downers addiction
Register Tags Mark Forums Read

Notices

Downers addiction Support for coping with benzodiazepine, barbiturate, and sedative-hypnotic drug addiction and downers addiction treatment.

Reply
 
Thread Tools Display Modes
  #1  
Old 07-11-2008, 00:36
Bajeda's Avatar
Bajeda Bajeda is nu online
Bajeda is winking at you.
Ethnobotanical Cannibal
Moderator
 
Join Date: 13-07-2006
Location: Funky Town
Posts: 4,837
Bajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond reputeBajeda is a true resource and beyond repute
Points: 15,834, Level: 18 Points: 15,834, Level: 18 Points: 15,834, Level: 18
Activity: 24% Activity: 24% Activity: 24%
The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients.

A new entry has been added to File Archive

Description:
E. SCHWEIZER, K. RICKELS, N. De MARTINIS, G. CASE and F. GARCÍA-ESPAÑA (1998). The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychological Medicine, 28(3): 713-720.

Background. Personality psychopathology exerts a significant and independent effect on the course of benzodiazepine (BZ) discontinuation, worsening the subjective severity of withdrawal symptoms and significantly increasing the occurrence of early taper failures.


Method. One hundred and seventy-one patients participating in a BZ discontinuation programme were administered several personality measures prior to taper. Patients were stabilized for 3 weeks at their baseline BZ dosage and then tapered off 25% per week over 4 weeks, with the option to extend up to 6 weeks if necessary.


Results. High levels of passivity and dependency as assessed by the MMPI Dependence subcluster, and at a trend level high Eysenck Neuroticism and high TPQ Harm Avoidance contributed significantly to the prediction of benzodiazepine withdrawal severity. Though there was a high correlation between personality measures, psychopathology and adjusted BZ dose, the effects of personality on withdrawal severity was significant, particularly in the initial phases of BZ taper, when taper severity was still relatively mild.


Conclusions. These findings indicate that clinical decisions on how to manage BZ tapering should be guided by personality assessments, in addition to the usual considerations of BZ dosage, residual psychopathology, duration of treatment, etc. The potential for difficulty with discontinuation related to personality traits should be one of the factors weighed in the risk–benefit assessment made in the planning of benzodiazepine treatment for patients with anxious symptomatology.

To check it out, rate it or add comments, visit The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients.
The comments you make there will appear in the posts below.
Reply With Quote
Reply

Bookmarks

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


Sitelinks: Site Functions:

All times are GMT +1. The time now is 20:37.


Copyright: Substance Information Network 2003 - 2009, All rights reserved